X4 Pharmaceuticals, Inc. (XFOR)
USD 0.64
(-13.21%)
USD 0.64
(-13.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 3 Million | - | 3.5 Million |
| Cost of Revenue | 1.99 Million | 1.99 Million | 1.89 Million | - | 672 Thousand | 103 Thousand |
| Gross Profit | -1.99 Million | -1.99 Million | -1.89 Million | 3 Million | -672 Thousand | 3.39 Million |
| Operating Expenses | 107.52 Million | 88.07 Million | 75.34 Million | 62.87 Million | 47.8 Million | 46.2 Million |
| Selling, General and Administrative Expenses | 35.5 Million | 27.02 Million | 24.7 Million | 20.94 Million | 17.64 Million | 18.4 Million |
| Research and Development Expenses | 72.01 Million | 61.05 Million | 50.64 Million | 41.93 Million | 30.16 Million | 30.97 Million |
| Other Expenses | - | -6.27 Million | -3.57 Million | -2.1 Million | -1.1 Million | -85 Thousand |
| Cost and Expenses | 107.52 Million | 88.07 Million | 75.34 Million | 62.87 Million | 47.8 Million | 46.2 Million |
| Operating Income | -107.52 Million | -87.56 Million | -85.1 Million | -59.87 Million | -51.7 Million | -45.88 Million |
| Interest Expense | 5.77 Million | 3.99 Million | 3.64 Million | 2.68 Million | 2.14 Million | 1.03 Million |
| Income Tax Expense | 78 Thousand | 28 Thousand | 17 Thousand | 148 Thousand | 3.79 Million | 3.9 Million |
| Earnings before Tax | -101.08 Million | -93.83 Million | -88.67 Million | -61.98 Million | -52.8 Million | -43.02 Million |
| Net Income | -101.16 Million | -93.86 Million | -88.69 Million | -62.13 Million | -56.6 Million | -43.02 Million |
| Earnings Per Share Basic | -0.57 | -1.48 | -3.44 | -3.09 | -4.91 | -93.73 |
| Earnings Per Share Diluted | -0.57 | -1.48 | -3.44 | -3.09 | -4.91 | -93.73 |
| Weighted Average Shares Outstanding | 177.81 Million | 63.52 Million | 25.74 Million | 20.07 Million | 11.53 Million | 459 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 177.81 Million | 63.52 Million | 25.74 Million | 20.07 Million | 11.53 Million | 459 Thousand |
| Gross Margin | - | - | - | 1.00 | - | 0.97 |
| EBIT Margin | - | - | - | -19.96 | - | -11.95 |
| Profit Margin | - | - | - | -20.71 | - | -12.29 |
| EBITDA | -107.1 Million | -87.56 Million | -85.1 Million | -58.06 Million | -51.7 Million | -45.88 Million |
| Earnings Before Tax Margin | - | - | - | -19.96 | - | -13.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 563 Thousand | - | 3.06 Million | - | - | - |
| Cost of Revenue | 462 Thousand | 62 Thousand | 62 Thousand | 1.99 Million | 502 Thousand | 516 Thousand |
| Gross Profit | 101 Thousand | -62 Thousand | 2.99 Million | -1.99 Million | -502 Thousand | -516 Thousand |
| Operating Expenses | 33.99 Million | 37.22 Million | 25.13 Million | 105.52 Million | 27.21 Million | 25.8 Million |
| Selling, General and Administrative Expenses | 13.27 Million | 17.43 Million | 9.92 Million | - | 8.13 Million | 10.2 Million |
| Research and Development Expenses | 20.72 Million | 19.79 Million | 15.21 Million | - | 19.08 Million | 15.6 Million |
| Other Expenses | 144 Thousand | 105 Thousand | 212 Thousand | - | 17 Thousand | -29.89 Million |
| Cost and Expenses | 34.46 Million | 37.28 Million | 25.19 Million | 107.52 Million | 27.21 Million | 25.8 Million |
| Operating Income | -33.89 Million | -37.28 Million | -25.19 Million | -107.52 Million | -27.21 Million | -25.8 Million |
| Interest Expense | 2.17 Million | 1.87 Million | 1.88 Million | 5.77 Million | 1.63 Million | 1.14 Million |
| Income Tax Expense | 18 Thousand | 19 Thousand | 33 Thousand | 78 Thousand | 26 Thousand | 15 Thousand |
| Earnings before Tax | 90.85 Million | -51.74 Million | -19.09 Million | -101.08 Million | -2.27 Million | -55.69 Million |
| Net Income | 90.83 Million | -51.76 Million | -19.13 Million | -101.16 Million | -2.3 Million | -55.71 Million |
| Earnings Per Share Basic | 0.45 | -0.26 | -0.10 | - | -0.01 | -0.33 |
| Earnings Per Share Diluted | 0.45 | -0.26 | -0.10 | - | -0.01 | -0.33 |
| Weighted Average Shares Outstanding | 200.44 Million | 199.99 Million | 198.76 Million | 177.81 Million | 196.98 Million | 168.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 200.8 Million | 199.99 Million | 198.76 Million | 177.81 Million | 196.98 Million | 168.73 Million |
| Gross Margin | 0.18 | - | 0.98 | - | - | - |
| EBIT Margin | -59.86 | - | -8.21 | - | - | - |
| Profit Margin | 161.34 | - | -6.25 | - | - | - |
| EBITDA | -33.7 Million | -37.22 Million | -25.13 Million | - | -25.7 Million | -25.8 Million |
| Earnings Before Tax Margin | -60.21 | - | -8.23 | - | - | - |
BCHHF
ALPEKA
CTV
AGAE
SXI
008060